Neurotrophic factor mimicry
Provides peptides that mimic BDNF and NGF to support neuronal survival and growth.


Cerebrolysin is administered via intramuscular or intravenous injection, typically in cycles of daily injections for 10-20 days. Dosing is determined by the clinical indication and patient response. Your provider will design the appropriate protocol based on your neurological health goals.
All dosing is determined by your licensed provider based on your health profile.
Do not self-administer without medical supervision.
Neurotrophic peptide preparation for brain health and cognitive recovery.
Starting at
All plans include doctor review, personalized treatment plan, and 24/7 provider access.
Cerebrolysin is administered via intramuscular or intravenous injection, typically in cycles of daily injections for 10-20 days. Dosing is determined by the clinical indication and patient response. Your provider will design the appropriate protocol based on your neurological health goals.
All dosing is determined by your licensed provider based on your health profile. Do not self-administer without medical supervision.
Cerebrolysin is a standardized preparation of low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain tissue. It has been manufactured and studied for over 40 years.
Cerebrolysin provides peptides that mimic the brain's own growth factors (BDNF and NGF), supporting neuronal survival, growth, and connectivity. It also reduces neuroinflammation and oxidative stress.
Cerebrolysin is approved as a prescription medication in over 40 countries worldwide for neurological conditions. In the United States, it is available through compounding pharmacies under physician supervision.
Cerebrolysin contains a mixture of low-molecular-weight neuropeptides and free amino acids that cross the blood-brain barrier. These peptides mimic the activity of naturally occurring neurotrophic factors (BDNF, NGF, CNTF), promoting neuronal survival, dendritic branching, and synaptic plasticity. Cerebrolysin also reduces neuroinflammation, decreases amyloid-beta aggregation, and supports neurogenesis. Its multi-target mechanism provides broad neuroprotective and neuroregenerative effects.
Cerebrolysin has been studied in over 150 clinical trials worldwide. A Cochrane systematic review evaluated its use in acute ischemic stroke. Phase III trials have demonstrated improvements in cognitive function and activities of daily living in patients with Alzheimer's disease. Studies published in journals including the Journal of Neural Transmission and Dementia and Geriatric Cognitive Disorders confirm its neurotrophic and neuroprotective properties.

Provides peptides that mimic BDNF and NGF to support neuronal survival and growth.
Low-molecular-weight peptides effectively reach brain tissue for direct neuroprotection.
Enhances the brain's ability to form and strengthen neural connections.
Addresses neuroinflammation, oxidative stress, and protein aggregation simultaneously.
Provides peptides that mimic BDNF and NGF to support neuronal survival and growth.
Low-molecular-weight peptides effectively reach brain tissue for direct neuroprotection.

Enhances the brain's ability to form and strengthen neural connections.
Addresses neuroinflammation, oxidative stress, and protein aggregation simultaneously.
Savings apply when multiple peptides are prescribed.
| BUNDLE SIZE | INCLUDED | SAVINGS |
|---|---|---|
| 2 Peptides | Simple paired therapy | SAVE 20• |
| 3 Peptides | Multi-pathway plan | SAVE 30• |
| 4 Peptides | Full personalized set | BEST VALUE |
• Results vary. Prescribed only when clinically appropriate.
Each plan may include several of the following formulations.
Every peptide we offer is backed by peer-reviewed research and clinical data. Our medical team stays current with the latest findings to ensure your protocol reflects the best available science.
Your medications arrive in unmarked, temperature-controlled packaging shipped directly from licensed compounding pharmacies. Privacy and quality guaranteed at every step.
Every treatment is prescribed and monitored by a licensed physician. Regular check-ins, lab reviews, and dosage adjustments ensure your peptide therapy is safe and effective throughout your journey.
Quick online assessment

Licensed provider reviews your medical history

Medication shipped directly once approved

Ongoing support and check-ins

Secure telehealth · GDPR-compliant · Pharmacy-grade compounding.
Not for self-administration. Reviewed by a medical provider.
All plans include a doctor review, personalized treatment plan (if approved), and 24/7 access to a licensed provider in your state.
Cerebrolysin is a standardized preparation of low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain tissue. It has been manufactured and studied for over 40 years.
Cerebrolysin provides peptides that mimic the brain's own growth factors (BDNF and NGF), supporting neuronal survival, growth, and connectivity. It also reduces neuroinflammation and oxidative stress.
Cerebrolysin is approved as a prescription medication in over 40 countries worldwide for neurological conditions. In the United States, it is available through compounding pharmacies under physician supervision.
Cerebrolysin may benefit individuals seeking to support cognitive function, those recovering from neurological events, or those looking to maintain brain health as they age. Candidacy is determined by your provider.
Standard protocols involve 10-20 days of daily injections, followed by a rest period before the next cycle. The number of cycles depends on your individual goals and response to treatment.
Doctor-guided peptide treatments personalized to your health goals. Start with a free consultation
Starting at
All plans include doctor review, personalized treatment plan, and 24/7 provider access.